Azab Lab/ Washington University in St. Louis
The azab lab from Washinton University in St. Louis is interested in understanding the biological mechanisms of proliferation and metastasis in cancer, including multiple myeloma, lymphoma and others. We are interested in understanding the mechanism involved in cell trafficking of cancer cells during proliferation metastasis. Particularly we are interested in the role of hypoxia and adhesion-molecules in promoting metastasis and drug resistance in these cancers. Our understanding of these mechanisms will help us design and develop novel drugs and therapeutic strategies which will be translated from-bench-to-bed. Cellatrix LLC is a spin-off company from the Azab Lab.
BioGenerator is an evergreen investor that creates, grows, and invests in promising companies and entrepreneurs in the St. Louis region. BioGenerator identifies and de-risks commercially promising innovations and services; advises innovators and entrepreneurs; recruits and supports entrepreneurial talent; makes staged investments grounded in rigorous due diligence; and offers access to lab space and capital equipment. We position companies to navigate the unique challenges of early-stage bioscience company development.